Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Progressive multifocal leukoencephalopathy
Joshua J. Chalkley
, Joseph R. Berger
Neurology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Progressive multifocal leukoencephalopathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
JC Virus
100%
Acquired Immune Deficiency Syndrome
100%
Virus
66%
Monoclonal Antibody
66%
Polyomavirus
66%
B Cell
33%
Immunosuppressive Drug
33%
Human Immunodeficiency Virus
33%
Capsid
33%
Alternative RNA Splicing
33%
Protein Structure
33%
Virus Particle
33%
Rituximab
33%
Papovavirus
33%
Glial Cell Culture
33%
BK Virus
33%
CD20
33%
Natalizumab
33%
Astrocyte
33%
Opportunistic Infection
33%
Mycophenolate Mofetil
33%
Integrin
33%
Medicine and Dentistry
Progressive Multifocal Leukoencephalopathy
100%
Acquired Immune Deficiency Syndrome
27%
JC Virus
27%
Diseases
27%
Neurologic Disease
18%
Virus
18%
Highly Active Antiretroviral Therapy
18%
Polyomavirus
18%
Monoclonal Antibody
18%
Disease
9%
Alternative RNA Splicing
9%
Receptor
9%
Human Immunodeficiency Virus
9%
Virus Capsid
9%
Virus Particle
9%
B Cell
9%
Regulator Protein
9%
Oligodendrocyte
9%
Glial Cells
9%
Natalizumab
9%
Genomic DNA
9%
Opportunistic Infection
9%
Virus Etiology
9%
Rhein
9%
Demyelination
9%
Protein Structure
9%
CD20
9%
Agnoprotein
9%
Protein VP1
9%
Protein VP2
9%
Protein VP3
9%
BK Virus
9%
Rituximab
9%
Orphan Disorder
9%
Papovavirus
9%
Mycophenolate Mofetil
9%
Cell Culture
9%
Immunosuppressive Drug
9%
Astrocyte
9%
Messenger RNA
9%
Integrin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Progressive Multifocal Leukoencephalopathy
100%
Diseases
36%
Acquired Immune Deficiency Syndrome
27%
JC Virus
27%
Neurologic Disease
18%
Monoclonal Antibody
18%
Polyomavirus
18%
Cell Culture
9%
HIV
9%
Regulator Protein
9%
Receptor
9%
Integrin
9%
Rituximab
9%
Immunosuppressive Agent
9%
Opportunistic Infection
9%
Demyelination
9%
Genomic DNA
9%
Mycophenolate Mofetil
9%
Papovavirus
9%
BK Virus
9%
Protein VP1
9%
Agnoprotein
9%
Virus Etiology
9%
Rhein
9%
Protein VP3
9%
Protein VP2
9%
Natalizumab
9%
Messenger RNA
9%
Neuroscience
Progressive Multifocal Leukoencephalopathy
100%
JC Virus
27%
Monoclonal Antibody
18%
Polyomavirus
18%
Nucleus
18%
Integrin
9%
Alternative Splicing
9%
Nervous System Disorder
9%
Glial Cells
9%
Regulator Protein
9%
Genomic DNA
9%
Rituximab
9%
Protein Structure
9%
Natalizumab
9%
Rhein
9%
CD20
9%
Agnoprotein
9%
Protein VP2
9%
Protein VP3
9%
Protein VP1
9%
Cell Culture
9%
Astrocyte
9%
Human Immunodeficiency Virus
9%
Oligodendrocyte
9%
B Cell
9%
Immunosuppressive Drug
9%
BK Virus
9%
Papovavirus
9%
Messenger RNA
9%
Receptor
9%
Mycophenolate Mofetil
9%
Veterinary Science and Veterinary Medicine
Progressive Multifocal Leukoencephalopathy
100%
Diseases
36%
Acquired Immune Deficiency Syndrome
27%
Neurologic Disease
18%
Monoclonal Antibody
18%
Protocerebrum
9%
Astrocyte
9%
B Cell
9%
Oligodendrocyte
9%
Opportunistic Infection
9%
Cell Culture
9%